Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,952 | -100.0% | 400,000 | 0.0% | 0.11% | -55.7% |
| Q3 2022 | $5,768,000 | -4.7% | 400,000 | 0.0% | 0.25% | -23.8% |
| Q2 2022 | $6,052,000 | +27.4% | 400,000 | 0.0% | 0.32% | +62.3% |
| Q1 2022 | $4,752,000 | -26.7% | 400,000 | 0.0% | 0.20% | +13.1% |
| Q4 2021 | $6,484,000 | -43.2% | 400,000 | 0.0% | 0.18% | -31.0% |
| Q3 2021 | $11,416,000 | -15.6% | 400,000 | 0.0% | 0.26% | -6.9% |
| Q2 2021 | $13,520,000 | +11.8% | 400,000 | 0.0% | 0.27% | +28.0% |
| Q1 2021 | $12,096,000 | -14.3% | 400,000 | +40.3% | 0.21% | -29.4% |
| Q4 2020 | $14,112,000 | +29.0% | 285,028 | 0.0% | 0.30% | +13.9% |
| Q3 2020 | $10,942,000 | -15.6% | 285,028 | -5.0% | 0.27% | -26.7% |
| Q2 2020 | $12,961,000 | +24.1% | 300,030 | -25.0% | 0.36% | -17.7% |
| Q1 2020 | $10,440,000 | -16.5% | 400,000 | 0.0% | 0.44% | -8.7% |
| Q4 2019 | $12,500,000 | +19.9% | 400,000 | 0.0% | 0.48% | +15.6% |
| Q3 2019 | $10,424,000 | +13.9% | 400,000 | 0.0% | 0.42% | +13.0% |
| Q2 2019 | $9,148,000 | +799.5% | 400,000 | +700.0% | 0.37% | +873.7% |
| Q4 2018 | $1,017,000 | -74.5% | 50,000 | -66.7% | 0.04% | -63.5% |
| Q3 2018 | $3,984,000 | – | 150,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |